[en] Adherence to the rules for antithrombotic ment in atrial fibrillation patients significantly reduces the risk of stroke. We review the criteria for the use of anti-vitamin K as well as its daily management in patients with atrial fibrillation.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
MELON, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
GARWEG, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
PA Wolf, RD Abbott, WB Kannel. - Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991, 22, 983-988.
Go AS. - The epidemiology of atrial fibrillation in eldery persons: the tip of the iceberg. Am J Geriatr Cardiol, 2005, 14, 56-61.
Risk factors for stroke and efficacy of antithrombotic therapyin atrial fibrillation: analysis od pooled datefrom five randomized control trials. Arch Intern Med, 1994, 154, 1449-1457.
Singer DE, Albers GW, Dalen JE, et al. - Antitrhombotic therapy in atrial fibrillation. American College of Chest Physicians Evidenced-based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133, 546S-592S.
Fuster V, Rydén LE, Cannom DS, et al. - ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol, 2006, 48, e149-e246.
Hart RG, pearce LA, McBride R, et al. - Factorss associated with ischemic stroke during aspirintherapy in atrial fibrillation : analysis of 2012 participants in the SPAFI-III clinical trials. Stroke, 1999, 30, 1223-1229.
Stroke prevention in Atrial Fibrillation Investigators. - Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Dis, 1995, 5, 147-157.
Gage BF, Waterman AD, Shannon W, et al.- Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA, 2001, 285, 2864-2870.
Gage BF, van Walraven C, Pearce l, et al. - Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation, 2004, 110, 2287-2292.
Ruiz-Nodar JM, Marin F, Hurtado JA, et al. - Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol, 2008, 51, 818-825.
Stroke Prevention in Atrial Fibrillation. - Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet, 1996, 348, 633-638.
Hylek EM, Go AS, Chang Y, et al. - Impact of intensity of oral anticoagulation on stroke severity and stroke mortality in patients with non-valvular atrial fibrillation. N Engl J Med, 2003, 349, 1019-1026.
Lown B. - Electrical reversion of arrhythmias. Br Heart J, 1967, 29, 469-489.
Goldman M. - The management of chronic atrial fibrillation: indications and method for conversion to sinus rhythm. Prog Cardiovasc Dis, 1959, 2, 465-479.
Collings LJ, Silverman DI, Douglas PS, et al. - Cardioversion of nonrheumatic atrial fibrillation: reduced thromboembolic complications wtih 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation, 1995, 92, 160-163.
O'Neill PG, Puleo PR, Bolli R, et al. - Return of atrial mechanical function following electrical cardioversion of atrial dysthythmias. Am Heart J, 1990, 120, 353-359. (Pubitemid 20229823)
Klein AL, Grimm RA, Murray MD, et al. - Use of transoesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med, 2001, 344, 1411-1420. (Pubitemid 32402097)
Douketis JD, Berger PB, Dunn AS, et al.- The Perioperative Management of Antithrombotic Therapy. American College of Chest Physicians Evidenced-based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133, 299S-339S.
Pengo V, Cucchini U, Denas G, for the Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic T. - Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery. an inception cohort management study. Circulation, 2009, 119, 2920-2927.
Fang MC, Chang Y, Hylek EM, et al. - Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med, 2004, 141, 745-752. (Pubitemid 39524912)
Connolly SJ, Ezekowitz MD, Yusuf S, et al. - Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009, 361, 1139-1151.